Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
391.94%Stock Based Compensation Margin
VS
Market
Sector
Industry
History
$ 2.54Close
$ 1.18 - $ 11.68 52-Week Range
Ticker Information
Ticker
BTAICompany Name
BIOXCEL THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQBIOXCEL THERAPEUTICS INC - Stock Based Compensation Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
BTAI - SB Comp % Historical data
| Date | Revenues | Stock Based Compensation | Stock Based Compensation Margin |
|---|---|---|---|
| 6/30/2025 | $ 868K | $ 3.4M | 391.94% |
| 3/31/2025 | $ 1.85M | $ 2.9M | 156.75% |
| 12/31/2024 | $ 2.27M | $ 6.16M | 271.67% |
| 9/30/2024 | $ 2.28M | $ 9.95M | 437.35% |
| 6/30/2024 | $ 2.4M | $ 12.1M | 503.66% |
| 3/31/2024 | $ 1.76M | $ 17.17M | 977.79% |
| 12/31/2023 | $ 1.38M | $ 18.61M | 1348.84% |
| 9/30/2023 | $ 1.24M | $ 19.56M | 1575.04% |
| 6/30/2023 | $ 1.04M | $ 20.03M | 1929.77% |
| 3/31/2023 | $ 581K | $ 18.39M | 3165.06% |
Key Performance Insights, Last 5 Years
- BIOXCEL THERAPEUTICS INC's latest trailing twelve months (TTM) SB Comp % stands at 0%.
- Over the past 5 years, BIOXCEL THERAPEUTICS INC's average SB Comp % has been 2195.75%.
- The median SB Comp % for BIOXCEL THERAPEUTICS INC during this period was 1163.32%
- BIOXCEL THERAPEUTICS INC reached its highest SB Comp % over the past 5 years at 10967.88%.
- The lowest SB Comp % recorded by BIOXCEL THERAPEUTICS INC in the same timeframe 156.75%
BIOXCEL THERAPEUTICS INC's SB Comp % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SB Comp % Benchmarks
Similar metrics to SB Comp %:
- Stock Based Compensation - [Cash Flow Statement] Stock Based Compensation, also called Share Based Compensation or Equity Compensation, is a method of paying directors, executives and employees with equity in the business. As non-cash expense, this element is added back when calculating net cash generated by operating activities [NCFO].
- Interest Expense Margin - [Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
Definition of Stock Based Compensation Margin
[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].SB Comp. / Revenues
(=) SB Comp % SB Comp % for BIOXCEL THERAPEUTICS INC is calculated as follows: SB Comp. [ $ 8.65M ] / Revenues [ $ 0 ]
(=) SB Comp % [ 0% ] BTAI - Stock Based Compensation Margin, Last 5 years
156.75%
Minimum
Mar 31, 2025
10967.88%
Maximum
Sep 30, 2022
2195.75%
Average
1163.32%
Median
SB Comp % Benchmark AnalysisMarket
The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
| filtered constituents | 2.98K |
|---|---|
| min | -3.97% |
| max | 8.43% |
| average | 1.72% |
| median | 1.04% |
| std | 1.9% |